ARCHEMIX CORP.
Patent Owner
Stats
- 7 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Jun 26, 2012 most recent publication
Details
- 7 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 1,135 Total Citation Count
- Sep 13, 2001 Earliest Filing
- 32 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
8207298 Methods of separating biopolymer conjugated molecules from unconjugated moleculesMay 01, 09Jun 26, 12[C07H, C07K, B01D]
8105813 Materials and methods for the generation of fully 2′-modified nucleic acid transcriptsJun 30, 06Jan 31, 12[C12N]
8101385 Materials and methods for the generation of transcripts comprising modified nucleotidesDec 21, 07Jan 24, 12[C12P, C12N]
7998940 Aptamers to von Willebrand factor and their use as thrombotic disease therapeuticsJan 29, 09Aug 16, 11[C07H, A01N, C12Q, C12P]
7589073 Aptamers to von Willebrand Factor and their use as thrombotic disease therapeuticsJan 12, 06Sep 15, 09[C07H, A01N, C12Q, C12P]
7566701 Aptamers to von Willebrand Factor and their use as thrombotic disease therapeuticsSep 07, 05Jul 28, 09[C07H, A01N, C12Q, C12P]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2011/0275,701 ANTI-THROMBIN APTAMER FORMULATIONS AND METHODS FOR USEAbandonedSep 11, 09Nov 10, 11[A61K, C07H, A61P]
7767803 Stabilized aptamers to PSMA and their use as prostate cancer therapeuticsExpiredMar 07, 06Aug 03, 10[A61K]
7579450 Nucleic acid ligands specific to immunoglobulin E and their use as atopic disease therapeuticsExpiredApr 26, 05Aug 25, 09[C07H]
2009/0142,855 Polynucleotides and Polypeptides of the IL-12 Family of CytokinesAbandonedJun 30, 06Jun 04, 09[C12P, C12N, G01N, C07K]
2009/0105,172 Stabilized Aptamers to PSMA and Their Use as Prostate Cancer TherapeuticsAbandonedMar 07, 06Apr 23, 09[A61K, C07H, C12Q, A61P]
2009/0075,342 Metabolic profile directed aptamer medicinal chemistryAbandonedApr 30, 08Mar 19, 09[C07H, C12P]
2009/0053,138 Stabilized Aptamers to Platelet Derived Growth Factor and their Use as Oncology TherapeuticsAbandonedNov 02, 05Feb 26, 09[A61K, C07H, A61P]
2009/0018,093 Nucleic Acid Ligands Specific to Immunoglobuline E and Their Use as Atopic Disease TherapeuticsAbandonedDec 01, 05Jan 15, 09[A61K, C07H, C12Q, A61P, C07K]
2008/0214,489 Aptamer-mediated intracellular delivery of oligonucleotidesAbandonedMar 12, 08Sep 04, 08[A61K]
2007/0066,550 Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeuticsAbandonedMar 07, 05Mar 22, 07[A61K, C07H]
2006/0193,821 Aptamers to the human IL-12 cytokine family and their use as autoimmune disease therapeuticsAbandonedSep 22, 05Aug 31, 06[A61K, C08G, C07K]
2006/0105,975 Aptamer-mediated intracellular delivery of therapeutic oligonucleotidesAbandonedApr 19, 05May 18, 06[A61K, C07H]
2006/0030,535 Controlled modulation of the pharmacokinetics and biodistribution of aptamer therapeuticsAbandonedMar 07, 05Feb 09, 06[A61K]
2005/0250,106 Gene knock-down by intracellular expression of aptamersAbandonedApr 23, 04Nov 10, 05[C07H, A61K, C12Q]
2005/0124,565 Stabilized aptamers to platelet derived growth factor and their use as oncology therapeuticsAbandonedJun 21, 04Jun 09, 05[A61K, C07H, C12N]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.
